| Administration of antibiotics by prolonged or continuous infusion in the inpatient setting
|
SESLHDPR/687 |
|
| Administration of Gastrografin™ in the treatment of Adhesional Small Bowel Obstruction
|
SESLHDGL/055 |
|
| Administration of Subcutaneous Medications in Palliative Care using a NIPRO Surefuser™
|
SESLHDPR/666 |
|
| Administration of subcutaneous medications in Palliative Care: a) Intermittent b) Via a syringe driver
|
SESLHDPR/175 |
|
| Advanced Recovery Orthopaedic Program (AROP) Anaesthetic Guideline
|
SESLHDGL/059 |
|
| Alerts Management – Electronic Recording of Alerts in eMR and iPM
|
SESLHDPR/582 |
|
| Alteplase (Recombinant Tissue Plasminogen Activator) in Adult Acute Ischaemic Stroke – Management of
|
SESLHDPR/236 |
|
| Antimicrobial Stewardship
|
SESLHDPD/137 |
|
| Assessment and Management of Headaches in Adults within SESLHD Emergency Departments
|
SESLHDGL/060 |
|
| Blood Borne Virus Testing
|
SESLHDPD/330 |
|
| Bowel Management
|
SESLHDGL/098 |
|
| Cancer Services – Use of eviQ Cancer Treatments Online
|
SESLHDPD/276 |
|
| Cannabis – Inpatient Management of patients admitted to SESLHD facilities using medicinal cannabis products
|
SESLHDPR/620 |
|
| Caring for COVID positive patients in the community
|
SESLHDPR/721 |
|
| Clinical Pathway Guideline
|
SESLHDGL/037 |
|
| Delirium - Prevention, Assessment and Management of Delirium in Older People
|
SESLHDPR/345 |
|
| Diphtheria, Tetanus and Pertussis vaccination for Ante/Postnatal Women
|
SESLHDPD/279 |
|
| Drug and Alcohol – Inpatient Management of Alcohol Withdrawal
|
SESLHDPR/238 |
|
| Guideline for Use of Complementary and Alternative Medicines in Hospital Inpatients
|
SESLHDGL/021 |
|
Heparin - Anticoagulation with Intravenous Heparin Sodium Infusion
|
SESLHDPR/402 |
|
| High-Risk Medicines Management
|
SESLHDPR/734 |
|
| HYDROmorphone in Adult Patients in SESLHD acute care facilities - management of
|
SESLHDPR/669 |
|
| Lumbar Puncture - Adult
|
SESLHDPR/613 |
|
| Management of Hypertension in the SESLHD Ward Settings
|
SESLHDGL/068 |
|
| Management of the Deteriorating ADULT inpatient (excluding maternity)
|
SESLHDPR/697 |
|
| Medication Charts: Charting of Oral Nutrition Support
|
SESLHDPR/317 |
|
| Medication: Administration by Enrolled Nurses
|
SESLHDPD/160 |
|
| Medicine: Continuity of Management and Documentation
|
SESLHDPR/267 |
|
Medicine: Drug Formulary Policy
|
SESLHDPD/183 |
|
| Medicine: Frusemide use in Adult Chronic Heart Failure Patients
|
SESLHDPD/169 |
|
| Medicine: Management of Refrigerated Storage of Medicines and Vaccinations in Clinical Areas
|
SESLHDPR/300 |
|
| Medicine: Managing Intraoperative Medications
|
SESLHDPR/209 |
|
| Medicine: Off-label use of registered medicines and use of unlicensed medicines
|
SESLHDPD/182 |
|
| Pain Management - Implantable Intrathecal Drug Delivery System
|
SESLHDPR/294 |
|
| Pain management - Ketamine Infusions for adult patients with acute and chronic non malignant pain
|
SESLHDPR/371 |
|
| Pain Management - Methoxyflurane Inhaler for Adult Patients
|
SESLHDPR/325 |
|
| Pain Management - Opioid Withdrawal in Patients on Long Term Opioid Medications
|
SESLHDPR/603 |
|
| Pain Management - Peripheral Nerve Analgesia (PNA)
|
SESLHDPR/372 |
|
| Palliative Care: administration of Adult Subcutaneous fluid
|
SESLHDPR/422 |
|
| Pharmacist Amendment of the Medication List in the electronic Discharge Referral Summary (eDRS)
|
SESLHDPR/327 |
|
| Respiratory Equipment – Cleaning and Decontamination
|
SESLHDPR/738 |
|
| Safe Handling and Management of Monoclonal Antibodies
|
SESLHDPR/368 |
|
| Safe Use of Opioids
|
SESLHDGL/105 |
|
| Smoking Cessation: Nurse/Midwife Initiated Nicotine Replacement Therapy (NRT)
|
SESLHDPR/494 |
|
| Student Clinical Placements in SESLHD Facilities
|
SESLHDPR/326 |
|
| Subcutaneous Administration of 4% Glucose and 0.18% Sodium Chloride in the treatment of hypernatraemia and dehydration in selected aged care patients with advanced dementia
|
SESLHDGL/069 |
|
| Urokinase: Administration of Intra-Arterial Urokinase in Specific Clinical Areas
|
SESLHDGL/038 |
|
| Use of Generic Medications
|
SESLHDPD/320 |
|
| Wound - Incontinence Associated Dermatitis (IAD)
|
SESLHDPR/205 |
|
